Showing results (51-60 of 566) with videos related to

Sort By:
Pageof 57
Cancer Research|January 1, 1990
Evaluation of ricin A chain-containing immunotoxins directed against the CD30 antigen as potential reagents for the treatment of Hodgkin's diseaseA Engert, F Burrows, W Jung, et al.
Leukemia & Lymphoma|August 1, 1995
Clinical experience with fludarabine and its immunosuppressive effects in pretreated chronic lymphocytic leukemias and low-grade lymphomasK Fenchel, L Bergmann, P Wijermans, et al.
International Journal of Cancer|October 9, 1995
Cocktails of ricin A-chain immunotoxins against different antigens on Hodgkin and Sternberg-Reed cells have superior anti-tumor effects against H-RS cells in vitro and solid Hodgkin tumors in miceA Engert, C Gottstein, H Bohlen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 12, 2008
Assessment of male fertility in patients with Hodgkin's lymphoma treated in the German Hodgkin Study Group (GHSG) clinical trialsM Sieniawski, T Reineke, A Josting, et al.
Cytokines and Molecular Therapy|December 1, 1996
Idiotype vaccination strategies against a murine B-cell lymphoma: dendritic cells loaded with idiotype and bispecific idiotype x anti-class II antibodies can protect against tumor growthH Bohlen, K Thielemanns, H Tesch, et al.
International Journal of Cancer|May 8, 2000
Recombinant anti-CD25 immunotoxin RFT5(SCFV)-ETA' demonstrates successful elimination of disseminated human Hodgkin lymphoma in SCID miceS Barth, M Huhn, B Matthey, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 1, 1992
Preliminary report: growth of Hodgkin's lymphoma derived cells in immune compromised miceU Kapp, J Wolf, C von Kalle, et al.
Leukemia & Lymphoma|April 30, 1999
Dexa-BEAM is not effective in patients with relapsed or resistant aggressive high-grade non-Hodgkin's lymphomaM Reiser, A Josting, P Dias Wickramanayake, et al.
Leukemia|January 19, 2000
Treatment of refractory Hodgkin's lymphoma patients with an anti-CD25 ricin A-chain immunotoxinR Schnell, E Vitetta, J Schindler, et al.
Leukemia & Lymphoma|December 30, 1998
DIZE (dexamethasone, idarubicin, and continuous infusion of ifosfamide and etoposide): an effective and well-tolerated new regimen for patients with relapsed lymphomaM Reiser, R Schnell, G Straub, et al.
Pageof 57